In this new episode of our Covid series, we are joined by Bruce Hellman and Jonathan Stone at uMotif. Bruce is the Co-Founder of the organisation, a leading patient centric eclinical platform. Jonathan is their Global Head of BD, having joined the organisation from Medidata as a multi-award winning sales professional. In this podcast, Bruce and Jonathan discuss the possible implications of Covid-19 on the biopharmaceutical and pharmatech markets.

For those interested to hear more from uMotif, their webinar focusing on patient centricity is available on demand here.

Listen to the Podcast below: